Evidence mapPaperPMID 41779276Full record

ArticleNeurochemical research2026

Analysis of Serum VCAN-AS1 Expression Level in Patients with Cerebral Infarction Secondary Epilepsy and Its Mechanism by Regulating miR-885-3p/NTNG1.

Yang Lin, Kun Zhang, Meijie Zhang, Lida Yin, Zhixin Liu, Yanru Meng, Yue Li, Jinhui Meng, Xueyong Yin, Liping Wang

Abstract read
PubMed Publisher
In one paragraph

Article in Neurochemical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yang Lin *Department of Neurology, Baotou Central Hospital, Baotou, 014040, China.
Kun Zhang *Guizhou Medical University, Guizhou, 550004, China.
Meijie ZhangDepartment of Rehabilitation, The Second Hospital of Qinhuangdao, Qinhuangdao, 066000, Hebei, China.
Lida YinDepartment of Pharmacy, The Second Hospital of Qinhuangdao, Qinhuangdao, 066000, Hebei, China.
Zhixin LiuMedical Section, The Second Hospital of Qinhuangdao, Qinhuangdao, 066000, Hebei, China.
Yanru MengDepartment of Rehabilitation, The Second Hospital of Qinhuangdao, Qinhuangdao, 066000, Hebei, China.
Yue LiDepartment of Rehabilitation, The Second Hospital of Qinhuangdao, Qinhuangdao, 066000, Hebei, China.
Jinhui MengRehabilitation Nursing, The Second Hospital of Qinhuangdao, Qinhuangdao, 066000, Hebei, China.
Xueyong YinDepartment of Traditional Chinese Medicine, The Second Hospital of Qinhuangdao, Qinhuangdao, 066000, Hebei, China.
Liping WangDepartment of Neurology, The Air Force Hospital of Southern Theater Command, PLA, No. 801 Dongfeng East Road, Yuexiu District, Guangzhou, 510602, Guangdong, China. wanglipingbt@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

VCAN-AS1 is a novel long non-coding RNA that participates in diverse disease processes, but the mechanism of its action in cerebral infarction secondary epilepsy (CISE) is unclear. The potential action mechanism of VCAN-AS1 in CISE was explored by this study. VCAN-AS1 and its downstream targets, namely miR-885-3p and Netrin G1 (NTNG1), were screened by the GEO, LncRNASNP2, and miRDB databases. The epileptic mouse and cell models were constructed using pilocarpine and the Mg

Indexed as

Cerebral InfarctionEpilepsyMicroRNAsRNA, Long NoncodingAnimalsHumansMaleMiceMice, Inbred C57BLMicroRNAsMIRN885 microRNA, humanRNA, Long NoncodingCerebral infarction secondary epilepsyFerroptosisInflammationLncRNA VCAN-AS1miR-885-3pNTNG1

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.